Health-Related Quality of Life in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Randomized Controlled Phase 3 Trial

被引:0
|
作者
Strand, Vibeke [1 ]
Dimonaco, Sophie [2 ]
Tuckwell, Katie [2 ]
Klearman, Micki [3 ]
Collinson, Neil [2 ]
Stone, John H. [4 ]
机构
[1] Stanford Univ, Div Immunol Rheumatol, Stanford, CA 94305 USA
[2] Roche Prod Ltd, Welwyn Garden City, Herts, England
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
892
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Chen, Chen
    Bovis, Francesca
    De Benedetti, Fabrizio
    Espada, Graciela
    Joos, Rik
    Akikusa, Jonathan
    Chaitow, Jeffrey
    Boteanu, Alina Lucica
    Kimura, Yukiko
    Rietschel, Christoph
    Siri, Daniel
    Smolewska, Elzbieta
    Schmeling, Heinrike
    Brown, Diane E.
    Martini, Alberto
    Lovell, Daniel J.
    Huang, Bin
    Ruperto, Nicolino
    ARTHRITIS CARE & RESEARCH, 2021, 73 (09) : 1264 - 1274
  • [22] ESTIMATING HEALTH-RELATED QUALITY OF LIFE IN FABRY DISEASE FOR PATIENTS TREATED WITH ENZYMEREPLACEMENT THERAPY IN THE BALANCE RANDOMIZED CONTROLLED TRIAL
    Lee, B.
    Hemstock, M.
    Stevenson, A.
    Stork, R.
    Azimpour, K.
    VALUE IN HEALTH, 2023, 26 (12) : S465 - S465
  • [23] Pharmacokinetics and Pharmacodynamics of Tocilizumab in Combination with Prednisone Tapering in Patients with Giant Cell Arteritis: 3-Year Results from a Randomized Controlled Phase 3 Trial
    Mallalieu, Navita
    Bao, Min
    Stone, John
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [24] Efficacy of Adjunctive Methotrexate in Patients with Giant Cell Arteritis Treated with Tocilizumab Plus Prednisone Tapering: Subanalysis of a Phase 3 Trial
    Stone, John H.
    Han, Jian
    Mohan, Shalini V.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [25] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Amsler, Jennifer
    Kysela, Iveta
    Tappeiner, Christoph
    Seitz, Luca
    Christ, Lisa
    Scholz, Godehard
    Stalder, Odile
    Kollert, Florian
    Reichenbach, Stephan
    Villiger, Peter M.
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [26] VISUAL LOSS IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB
    Amsler, J.
    Kysela, I.
    Christ, L.
    Tappeiner, C.
    Seitz, L.
    Scholz, G.
    Kollert, F.
    Reichenbach, S.
    Villiger, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 95 - 95
  • [27] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Jennifer Amsler
    Iveta Kysela
    Christoph Tappeiner
    Luca Seitz
    Lisa Christ
    Godehard Scholz
    Odile Stalder
    Florian Kollert
    Stephan Reichenbach
    Peter M. Villiger
    Arthritis Research & Therapy, 23
  • [28] Health-related quality of life in patients with glioblastoma: a randomised controlled trial
    Taphoorn, MJB
    Stupp, R
    Coens, C
    Osoba, D
    Kortmann, R
    van den Bent, MJ
    Mason, W
    Mirimanoff, RO
    Baumert, BG
    Eisenhauer, E
    Forsyth, P
    Bottomley, A
    LANCET ONCOLOGY, 2005, 6 (12): : 937 - 944
  • [29] Health-related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial
    Peris, Ketty
    Inocencio, Timothy J.
    Stratigos, Alexander J.
    Lewis, Karl D.
    Eroglu, Zeynep
    Chang, Anne Lynn S.
    Ivanescu, Cristina
    Sekulic, Aleksandar
    Fury, Matthew G.
    Chen, Chieh-, I
    Quek, Ruben G. W.
    CANCER MEDICINE, 2024, 13 (14):
  • [30] Low Immunogenicity in Patients with Giant Cell Arteritis Treated with Tocilizumab: 3-Year Results from the Randomized Controlled Portion and the Open-Label Follow-Up of a Phase 3 Trial
    Stone, John H.
    Mallalieu, Navita L.
    Bao, Min
    ARTHRITIS & RHEUMATOLOGY, 2020, 72